山东大学学报 (医学版) ›› 2023, Vol. 61 ›› Issue (12): 107-112.doi: 10.6040/j.issn.1671-7554.0.2023.0793
• 病例报道 • 上一篇
刘庆燕1,2,3,王翰博4,包瑾瑾1,2,3,苏文敬5,刘佳1,2,3
中图分类号:
| [1] Hiraishi K, Yoshimoto T, Tsuchiya K, et al. Clinicopathological features of primary aldosteronism associated with subclinical Cushings syndrome[J]. Endocrine J, 2011, 58(7): 543-551. [2] Hogan MJ, Schambelan M, Biglieri EG. Concurrent hypercortisolism and hypermineralocorticoidism[J]. The Am J Med, 1977, 62(5): 777-782. [3] Katabami T, Matsuba R, Kobayashi H, et al. Primary aldosteronism with mild autonomous cortisol secretion increases renal complication risk[J]. Eur J Endocrinol, 2022, 186(6): 645-655. [4] Akehi Y, Yanase T, Motonaga R, et al. High prevalence of diabetes in patients with primary aldosteronism(PA)associated with subclinical hypercortisolism and prediabetes more prevalent in bilateral than unilateral PA: a large, multicenter cohort study in Japan[J]. Diabetes Care, 2019, 42(5): 938-945. [5] Arlt W, Lang K, Sitch AJ, et al. Steroid metabolome analysis reveals prevalent glucocorticoid excess in primary aldosteronism[J]. JCI Insight, 2017, 2(8): 93136. [6] Teragawa H, Oshita C, Orita Y, et al. Primary aldosteronism due to bilateral micronodular hyperplasia and concomitant subclinical Cushings syndrome: a case report[J]. World J Clin Cases, 2021, 9(5): 1119-1126. [7] Hu L, Ji W, Guo M, et al. Case report: primary aldosteronism and subclinical cushing syndrome in a 49-year-old woman with hypertension plus hypokalaemia[J]. Front Cardiovasc Med, 2022, 9: 911333. doi:10.3389/fcvm.2022.1055119. [8] Yoon V, Heyliger A, Maekawa T, et al. Benign adrenal adenomas secreting excess mineralocorticoids and glucocorticoids[J].Endocrinol Diabetes Metab Case Rep, 2013, 2013: 130042. doi:10.1530/edm-13-0042. [9] Vicennati V, Repaci A, di Dalmazi G, et al. Combined aldosterone and cortisol secretion by adrenal incidentaloma[J]. Int J Surg Pathol, 2012, 20(3): 316-319. [10] 中华医学会内分泌学分会.原发性醛固酮增多症诊断治疗的专家共识(2020版)[J].中华内分泌代谢杂志, 2020, 36(9): 727-736. Chinese Society of Endocrinology, Chinese Medical Association. Expert consensus on the diagnosis and treatment of primary aldosteronism(2020)[J]. Chinese Journal of Endocrinology and Metabolism, 2020, 36(9): 727-736. [11] 李乐乐,窦京涛. 如何从肾上腺意外瘤中甄选出亚临床库欣综合征[J]. 中国实用内科杂志,2017, 37(10): 867-870. LI Lele, DOU Jingtao. Proposed diagnostic strategy for subclinical Cushings syndrome in patients with adrenal incidentaloma[J]. China Industrial Economics, 2017, 37(10): 867-870. [12] Akehi Y, Kawate H, Murase K, et al. Proposed diagnostic criteria for subclinical Cushings syndrome associated with adrenal incidentaloma[J]. Endocr J, 2013, 60(7): 903-912. [13] Al-Salameh A, Baudry C, Cohen R. Update on multiple endocrine neoplasia Type 1 and 2[J]. Presse Med, 2018, 47(9): 722-731. [14] Thakker RV, Newey PJ, Walls GV,et al. Clinical practice guidelines for multiple endocrine neoplasia type 1(MEN1)[J]. J Clin Endocrinol Metab, 2012, 97(9): 2990-3011. [15] Funder JW, Carey RM, Fardella C, et al.Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline[J]. J Clin Endocrinol Metab, 2008, 93(9): 3266-3281. [16] Rossi GP, Auchus RJ, Brown M, et al. An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism[J]. Hypertension, 2014, 63(1): 151-160. [17] Goupil R, Wolley M, Ungerer J, et al. Use of plasma metanephrine to aid adrenal venous sampling in combined aldosterone and cortisol over-secretion[J]. Endocrinol Diabetes Metab Case Rep, 2015, 2015: 150075.doi: 10.1530/EDM-15-0075. [18] Mete O, Erickson LA, Juhlin CC, et al. Overview of the 2022 WHO classification of adrenal cortical tumors[J]. Endocr Pathol, 2022, 33(1): 155-196. [19] Scortegagna M, Berthon A, Settas N, et al. The E3 ubiquitin ligase Siah1 regulates adrenal gland organization and aldosterone secretion[J]. JCI Insight, 2017, 2(23): 97128. [20] Nanba K, Tsuiki M, Sawai K, et al. Histopathological diagnosis of primary aldosteronism using CYP11B2 immunohistochemistry[J]. J Clin Endocrinol Metab, 2013, 98(4): 1567-1574. [21] Nakamura Y, Yamazaki Y, Tezuka Y, et al. Expression of CYP11B2 in aldosterone-producing adrenocortical adenoma: regulatory mechanisms and clinical significance[J]. Tohoku J Exp Med, 2016, 240(3): 183-190. [22] Ahn CH, Na HY, Park SY, et al. Expression of CYP11B1 and CYP11B2 in adrenal adenoma correlates with clinical characteristics of primary aldosteronism[J]. Clin Endocrinol, 2022, 96(1): 30-39. [23] Raff H, Carroll T. Cushings syndrome: from physiological principles to diagnosis and clinical care[J]. J Physiol, 2015, 593(3): 493-506. [24] Ferriere A, Tabarin A. Cushings syndrome: treatment and new therapeutic approaches[J]. Best Pract Res Clin Endocrinol Metab, 2020, 34(2): 101381. |
| [1] | 许琴,高梅,王海民,曹凌瑕,孙成林. 常染色体显性多囊肾病伴原发性醛固酮增多症1例[J]. 山东大学学报 (医学版), 2020, 58(4): 118-120. |
| [2] | 刘贺,刘福强,侯新国,陈丽. CYP11B1基因新突变致11β-羟化酶缺陷症1例家系研究[J]. 山东大学学报（医学版）, 2017, 55(9): 85-89. |
| [3] | 杨学成1，孙瑞霞2，范靓靓3，王开平2，矫文娟2，曹彩霞2，高燕燕2，孙立江1，王新生1. 类固醇合成酶在亚临床库欣综合征患者中的表达及意义[J]. 山东大学学报(医学版), 2012, 50(12): 87-. |
| [4] | 郭旭东1，王翰博1，蒋绍博1，金讯波1，巩若箴2，熊晖1. 腹腔镜肾上腺全切术与部分切除术治疗肾上腺醛固酮腺瘤的对比研究[J]. 山东大学学报(医学版), 2011, 49(11): 146-. |
| [5] | 蒋绍博1，金讯波1，王翰博1，巩若箴2，郭旭东1，熊晖1，王正1. 腹腔镜单侧肾上腺切除术治疗肾上腺结节样增生性原发性醛固酮增多症的效果评价[J]. 山东大学学报(医学版), 2011, 49(10): 131-. |
|
||
